In this podcast, Nolan R. Williams, MD, discusses the Stanford Accelerated Intelligent Neuromodulation Therapy protocol, which reduced severe depression symptoms in 90% of participants in a small trial. ...
In this Q&A, lead author Shahina Pardhan, PhD, discusses her study that found dual sensory impairment is associated with increased depression and anxiety, with women showing stronger associations than...
What is the association between depression and subsequent risk of rheumatoid arthritis by serologic phenotype? In this Q&A, Jeffrey Sparks, MD, explains.
Dr Jennifer Dwyer discusses the results from her randomized, double-blind, placebo-controlled crossover trial study that found a reduction in depression scores at 24 hours post treatments with ketamine...
Rashi Aggarwal, MD, from Rutgers New Jersey Medical School, discusses screening tools and treatment options for diagnosing and managing posttraumatic stress disorder in the primary care setting.
In this video, Charles Conway, MD, summarizes new research supporting the use of nitrous oxide for the treatment of treatment-resistant major depression (TRMD).
In part 2 of this video, Charles Conway, MD, covers possible side effects of the use of nitrous oxide for the treatment of treatment-resistant major depression , and next steps for continued research....
Stanislav Spivak, MD, Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University and Medical Director of the Johns Hopkins Psychiatric Mobile Treatment program discusses the...
In this video, Manish Jha, MBBS, reviews the key take-home points from his session on effectively treating anxiety disorders in primary care, which he presented at our Practical Updates in Primary Care 2021...
In part 1 of this podcast series, Robert S. Laitman, MD, from Bronx Westchester Medical Group and SARDAA, discusses the 5 criteria used to help diagnose schizophrenia, as well as the differential...
